NASDAQ •
Financial Services •
Asset Management •
Quote as of 09/11/2026
Company Profile
IndustryAsset Management
SectorFinancial Services
ExchangeNASDAQ
Market Capitalization244.09 mln
Float86.58 mln
Earnings Date11/16/2026
EPS
0.64
Decent
P / E
3.54
Deeply undervalued
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
4.90
Transformational upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
Business Description
Founded in 2011 and headquartered in Cambridge, Massachusetts, Cypherpunk Technologies Inc. builds and invests in privacy-focused digital technologies, with Zcash serving as the foundation of its digital asset holdings. The company also researches and develops antibody-based treatments targeting cancer and related conditions, including DKN-01, which has completed a Phase 2 trial for colorectal cancer, and FL-501, an early-stage therapy aimed at cancer-related weight loss, severe pregnancy nausea, and conditions linked to aging. Previously operating as Leap Therapeutics, the company adopted its current name in November 2025.
